Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$128.39
-1.8%
$142.27
$123.00
$225.00
$3.86B1.25551,519 shs301,417 shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€24.59
+0.4%
€23.25
€17.12
€25.88
€7.45B0.55336,887 shs190,500 shs
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$334.75
$332.85
$157.00
$334.90
$12.57B0.88968,088 shsN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$119.90
-1.4%
$123.44
$115.94
$249.91
$5.37B1.08630,875 shs360,058 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-1.71%-1.23%-7.25%-9.26%-4.03%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
+0.29%-2.58%+12.59%+29.35%+36.76%
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.00%0.00%0.00%0.00%0.00%
Teleflex Incorporated stock logo
TFX
Teleflex
-1.23%+0.38%-1.28%-9.12%-43.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.853 of 5 stars
4.41.00.04.83.32.51.9
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
1.0645 of 5 stars
0.02.00.80.02.00.01.9
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
4.6941 of 5 stars
3.04.02.53.92.41.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.73
Moderate Buy$211.9165.06% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.86
Moderate BuyN/AN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.00
N/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
2.09
Hold$164.6337.30% Upside

Current Analyst Ratings Breakdown

Latest STVN, INSP, SWAV, and TFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$220.00 ➝ $200.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$235.00 ➝ $195.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$195.00 ➝ $174.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$230.00 ➝ $236.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$140.00 ➝ $137.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$191.00 ➝ $173.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$150.00 ➝ $145.00
5/2/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$146.00 ➝ $137.00
4/21/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$190.00 ➝ $175.00
4/21/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$234.00 ➝ $216.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$802.80M4.72$1.68 per share76.51$23.01 per share5.58
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.12B6.62€0.76 per share32.43€5.02 per share4.90
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$787.97M15.95$4.31 per share77.61$20.02 per share16.72
Teleflex Incorporated stock logo
TFX
Teleflex
$3.01B1.76$25.03 per share4.79$92.11 per share1.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$53.51M$2.1759.1639.872.007.92%10.00%8.68%8/5/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5148.2242.402.3411.14%10.00%6.03%N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$147.28M$4.2878.2154.342.4320.75%24.79%11.95%N/A
Teleflex Incorporated stock logo
TFX
Teleflex
$69.68M$3.1737.827.901.904.96%14.73%8.79%7/30/2025 (Estimated)

Latest STVN, INSP, SWAV, and TFX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.23$0.10+$0.33$0.10$194.89 million$201.32 million
5/1/2025Q1 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$2.88$2.91+$0.03$2.07$699.37 million$700.67 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.13%N/A42.90%N/A

Latest STVN, INSP, SWAV, and TFX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
annual€0.060.3%6/5/20256/5/20257/17/2025
5/12/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.09%5/20/20255/20/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
9.01
7.44
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.22
1.83
1.26
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.97
13.81
12.61
Teleflex Incorporated stock logo
TFX
Teleflex
0.44
2.28
1.32

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
95.35%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.10%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
3.40%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,24629.49 million28.29 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 million300.72 millionOptionable
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
1,46837.54 million36.27 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,10044.19 million43.57 millionOptionable

Recent News About These Companies

Teleflex closes deal with BIOTRONIK
Teleflex (NYSE:TFX) Stock Rating Lowered by Wall Street Zen
Zacks Research Has Bearish Forecast for Teleflex Q2 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$128.38 -2.34 (-1.79%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$128.38 0.00 (0.00%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€24.59 +0.11 (+0.45%)
As of 07/3/2025 03:30 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Shockwave Medical stock logo

Shockwave Medical NASDAQ:SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Teleflex stock logo

Teleflex NYSE:TFX

$119.90 -1.69 (-1.39%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$122.09 +2.19 (+1.83%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.